Scope and Application:
The USQ Institutional Biosafety Committee assesses and reviews all research proposals involving the use of genetic manipulation technologies as well as certifying PC2 physical containment facilities and, where required by the guidelines, submits them to the Office of the Genetic Technology Regulator (OGTR) for assessment. The OGTR is responsible for overseeing the development and use of novel genetic manipulation techniques in Australia.
A meeting must be held annually during August when the draft Annual Report can be reviewed and endorsed by members prior to its submission to the Office of the Genetic Technology Regulator (OGTR) by the required date.
The USQ Institutional Biosafety Committee reports to the Vice-Chancellor through the Research Committee. The OGTR has been advised of the following Committee membership:
Prof G Daggard
(Molecular biology expertise)
Assoc Prof M Kotiw (Secretary, Molecular microbiology)
Prof G Daggard (Molecular biology expertise)
Dr D Coates (Experience and expertise in ethical issues)
Mr D Stranger (Clinical microbiology expertise)
Dr P Banks (Plant geneticist)
Mr J Taylor (Veterinary pathologist)
Mrs M McLean (Farmer)
Mr P McConnell (Biological Safety Officer)
Dr S Hazell (Infectious disease expertise)
Term of Office: Three years, up to but not including, the regular meeting of the Research in August 2009.
Peak Approval Authority:
Endorse policy and approve procedure
Related Legislation / guidelines:
Strategic Plan/Goal & Objectives:
Supporting documents, forms:
Associated USQ policies:
Next Review Date*:
Expiry Date of Policy: